Alkalon developes and supplies medical chewing gum including competitive chewing gum to brands around the world.
Our team of experts has created a range of new flavours of which just a few have been carefully selected to undergo full development.
Crunchy coating
We coat our products with maltitol, which gives our gums a crunchier outside than the xylitol coatings on existing products.
Same release profile as Nicorette®
Our products release nicotine at the same rate as the reference product, Nicorette®. We use a modified buffering system which provides the required buccal absorption of nicotine but reduces the acrid taste of normal buffer systems.
NICOTINE GUM
Alkalon offers a range of finished product formulations and is seeking partnership opportunities worldwide
NICOTINE GUM
Nicotine Replacement Therapy (NRT) is in the top-7 of OTC categories.
High growth rates, low competition and governmental anti-smoking campaigns have made nicotine gums one of the most sold OTC products in North-European countries.
2007
The company was founded in Denmark in 2007. Our mission is to develop top quality generic nicotine gums.
2008
Alkalon signed the first license and supply agreement with a large Pharma company.
2010
The company finalized formulation development and scale-up of its first products.
2011
Alkalon filed for European approval and started offering contract research and product development services to the pharmaceutical industry.
2012
First launched by the Scandinavian partner Orifarm under the Nicovel® name Alkalon’s products reached the market in a number of European countries.
2015
Alkalon merge with Revolymer and gain access to the North American market
Alkalon has nicotine gum dossiers available for in-licensing and offers to supply the finished products packed and ready for sale.
We have MAs available for a number of European countries and the registration is ongoing in several territories outside of Europe.
Experiencing side effects?
Do you have questions regarding the use of our medicinal products, or do you want to report a side effect?
Please fill out the form on this link, or you can contact us 24/7 on Phone +45 38 86 84 82
Claus Faurschou Larsen
Chief Operations Officer
Office tel.: +45 38 86 84 82
Mobile tel.: +45 50 62 27 91
E-mail: cf@alkalon com
Jeanette Senker Holbech
Head of Administration
Office tel.: +45 38 86 84 82
Mobile tel.: +45 24 43 41 95
E-mail: jsh@alkalon com
Farverland 6, st.
DK-2600 Glostrup l Copenhagen DENMARK
Telephone: +45 38 86 84 82
E-mail: office@alkalon.com
CVR-nr: 30273826
VAT no.: DK30273826 l Pnr: 1020242910
I’m here to help!
Kristian Uggerhøj
CEO
Office tel.: +45 38 86 84 82
or use the bottom: